*ST Xianfeng (002141.SZ): Initial repurchase of 1.051,000 shares involving 1,038,200 yuan

Gelonghui, May 17丨*ST Xianfeng (002141.SZ) announced that on May 17, 2024, for the first time, the company repurchased 1,0501.07 million shares of the company's shares through a special stock repurchase account, accounting for 0.09% of the company's total share capital (based on the company's total share capital as of May 17, 2024). The maximum transaction price was 0.99 yuan/share, and the minimum transaction price was 0.98 yuan/share, with a transaction amount of 1,038,200 yuan (excluding transaction fees).

Gelonghui FinanceMay 17 06:32 ET

*ST Xianfeng (002141.SZ) received a warning letter from the Guangdong Securities Regulatory Bureau

Zhitong Finance App News, *ST Xianfeng (002141.SZ) issued an announcement. The company received the “Decision on Issuing Warning Letter Measures against Xianfeng Holdings Co., Ltd., Han Peach, Ding Chen, Xie Wenbin, Zhang Yangyu, etc.” ([2024] No. 39) issued by the Guangdong Securities Regulatory Bureau on May 16, 2024. After investigation, on April 26, 2024, Xianfeng Holdings disclosed the “Notice on Correction of Early Accounting Errors” because the company Chengdu Shiji Biopharmaceutical Co., Ltd. (hereinafter referred to as Shiji Biotech) improperly confirmed its main business revenue and inflated revenue, which led to the company's first quarter report of 2023

Zhitong FinanceMay 16 08:46 ET

Xianfeng Holdings (002141.SZ) reported first-quarter results with a net loss of 153,800 yuan

According to Zhitong Finance App, Xianfeng Holdings (002141.SZ) released its report for the first quarter of 2024. During the reporting period, the company achieved operating income of 16.649,900 yuan, a year-on-year decrease of 20.30%; net loss attributable to shareholders of listed companies was 153,800 yuan; net loss attributable to shareholders of listed companies deducted 8.68777 million yuan for non-recurring profit and loss; basic loss per share was 0.0001 yuan/share.

Zhitong FinanceApr 29 12:00 ET

Xianfeng Holdings (002141.SZ): Stock trading may be subject to a delisting risk warning

Gelonghui, April 19 | Xianfeng Holdings (002141.SZ) announced that the company expects net profit attributable to shareholders of listed companies in 2023 to be negative and operating income after deduction to be less than 100 million yuan. According to the relevant provisions of the current “Shenzhen Stock Exchange Stock Listing Rules”, the company's stock transactions may be subject to a delisting risk warning after the disclosure of the company's 2023 annual report.

Gelonghui FinanceApr 19 10:51 ET

Xianfeng Holdings (002141.SZ): Not engaged in pig business

Gelonghui, April 12 | Xianfeng Holdings (002141.SZ) said on the investor interactive platform that the company's main business is the veterinary vaccine business. The main products are pig vaccines, and it is not engaged in the pig business.

Gelonghui FinanceApr 12 05:29 ET

Xianfeng Holdings (002141.SZ): The company's stock trading may be subject to a delisting risk warning

Gelonghui, Feb. 21丨Xianfeng Holdings (002141.SZ) announced that the company expects net profit attributable to shareholders of listed companies in 2023 to be negative and operating income less than 100 million yuan after deduction. According to the relevant provisions of the current “Shenzhen Stock Exchange Stock Listing Rules”, the company's stock transactions may be subject to a delisting risk warning after the disclosure of the company's 2023 annual report.

Gelonghui FinanceFeb 21 04:02 ET